185 related articles for article (PubMed ID: 30840061)
21. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.
Irani SR; Bera K; Waters P; Zuliani L; Maxwell S; Zandi MS; Friese MA; Galea I; Kullmann DM; Beeson D; Lang B; Bien CG; Vincent A
Brain; 2010 Jun; 133(Pt 6):1655-67. PubMed ID: 20511282
[TBL] [Abstract][Full Text] [Related]
22. Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis.
Pollak TA; Kempton MJ; Iyegbe C; Vincent A; Irani SR; Coutinho E; Menassa DA; Jacobson L; de Haan L; Ruhrmann S; Sachs G; Riecher-Rössler A; Krebs MO; Amminger P; Glenthøj B; Barrantes-Vidal N; van Os J; Rutten BPF; Bressan RA; van der Gaag M; Yolken R; Hotopf M; Valmaggia L; Stone J; David AS; ; McGuire P
Mol Psychiatry; 2021 Jun; 26(6):2590-2604. PubMed ID: 33077853
[TBL] [Abstract][Full Text] [Related]
23. Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients.
Purde MT; Niederer R; Wagner NB; Diem S; Berner F; Hasan Ali O; Hillmann D; Bergamin I; Joerger M; Risch M; Niederhauser C; Lenz TL; Früh M; Risch L; Semela D; Flatz L
J Cancer Res Clin Oncol; 2022 Mar; 148(3):647-656. PubMed ID: 34874490
[TBL] [Abstract][Full Text] [Related]
24. Routine diagnostics for neural antibodies, clinical correlates, treatment and functional outcome.
Bien CG; Bien CI; Dogan Onugoren M; De Simoni D; Eigler V; Haensch CA; Holtkamp M; Ismail FS; Kurthen M; Melzer N; Mayer K; von Podewils F; Rauschka H; Rossetti AO; Schäbitz WR; Simova O; Witt K; Höftberger R; May TW
J Neurol; 2020 Jul; 267(7):2101-2114. PubMed ID: 32246252
[TBL] [Abstract][Full Text] [Related]
25. Neuronal autoantibodies in epilepsy patients with peri-ictal autonomic findings.
Baysal-Kirac L; Tuzun E; Erdag E; Ulusoy C; Vanli-Yavuz EN; Ekizoglu E; Peach S; Sezgin M; Bebek N; Gurses C; Gokyigit A; Vincent A; Baykan B
J Neurol; 2016 Mar; 263(3):455-66. PubMed ID: 26725084
[TBL] [Abstract][Full Text] [Related]
26. A prospective three-year follow-up study on the clinical significance of anti-neuronal antibodies in acute psychiatric disorders.
Schou MB; Sæther SG; Drange OK; Brenner E; Crespi J; Eikenes L; Mykland MS; Pintzka C; Håberg AK; Sand T; Vaaler A; Kondziella D
Sci Rep; 2019 Dec; 10(1):35. PubMed ID: 31896766
[TBL] [Abstract][Full Text] [Related]
27. Autoimmune channelopathies in paraneoplastic neurological syndromes.
Joubert B; Honnorat J
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2665-76. PubMed ID: 25883091
[TBL] [Abstract][Full Text] [Related]
28. Neurological Autoantibody Prevalence in Epilepsy of Unknown Etiology.
Dubey D; Alqallaf A; Hays R; Freeman M; Chen K; Ding K; Agostini M; Vernino S
JAMA Neurol; 2017 Apr; 74(4):397-402. PubMed ID: 28166327
[TBL] [Abstract][Full Text] [Related]
29. Antibodies in Autoimmune Human Neurological Disease: Pathogenesis and Immunopathology.
Williams JP; Carlson NG; Greenlee JE
Semin Neurol; 2018 Jun; 38(3):267-277. PubMed ID: 30011408
[TBL] [Abstract][Full Text] [Related]
30. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus.
Hanly JG; Robichaud J; Fisk JD
J Rheumatol; 2006 Aug; 33(8):1553-8. PubMed ID: 16881112
[TBL] [Abstract][Full Text] [Related]
31. Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus.
Lapteva L; Nowak M; Yarboro CH; Takada K; Roebuck-Spencer T; Weickert T; Bleiberg J; Rosenstein D; Pao M; Patronas N; Steele S; Manzano M; van der Veen JW; Lipsky PE; Marenco S; Wesley R; Volpe B; Diamond B; Illei GG
Arthritis Rheum; 2006 Aug; 54(8):2505-14. PubMed ID: 16868971
[TBL] [Abstract][Full Text] [Related]
32. Clinical relevance of serum antibodies to extracellular N-methyl-D-aspartate receptor epitopes.
Zandi MS; Paterson RW; Ellul MA; Jacobson L; Al-Diwani A; Jones JL; Cox AL; Lennox B; Stamelou M; Bhatia KP; Schott JM; Coles AJ; Kullmann DM; Vincent A
J Neurol Neurosurg Psychiatry; 2015 Jul; 86(7):708-13. PubMed ID: 25246644
[TBL] [Abstract][Full Text] [Related]
33. Correlations between the level of antibody against peptide of glutamate receptor NR3B subunit in the CSF and cognitive comorbidities of patients with epilepsy.
Li XY; Hu P; Li QY; Zhang M; Lai QW; Wang X; Fan HB; Yao RQ
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):328-337. PubMed ID: 30657574
[TBL] [Abstract][Full Text] [Related]
34. Stroke patients develop antibodies that react with components of N-methyl-D-aspartate receptor subunit 1 in proportion to lesion size.
Kalev-Zylinska ML; Symes W; Little KC; Sun P; Wen D; Qiao L; Young D; During MJ; Barber PA
Stroke; 2013 Aug; 44(8):2212-9. PubMed ID: 23723305
[TBL] [Abstract][Full Text] [Related]
35. [Paraneoplastic neurological syndromes with reference to anti-neuronal autoantibodies].
Tanaka K
Rinsho Shinkeigaku; 2010 Jun; 50(6):371-8. PubMed ID: 20593661
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy.
Brenner T; Sills GJ; Hart Y; Howell S; Waters P; Brodie MJ; Vincent A; Lang B
Epilepsia; 2013 Jun; 54(6):1028-35. PubMed ID: 23464826
[TBL] [Abstract][Full Text] [Related]
37. N-methyl-d-aspartate receptor autoimmunity affects cognitive performance in herpes simplex encephalitis.
Westman G; Studahl M; Ahlm C; Eriksson BM; Persson B; Rönnelid J; Schliamser S; Aurelius E
Clin Microbiol Infect; 2016 Nov; 22(11):934-940. PubMed ID: 27497810
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of antineuronal antibodies in patients with encephalopathy of unknown etiology: Data from a nationwide registry in Korea.
Byun JI; Lee ST; Jung KH; Sunwoo JS; Moon J; Kim TJ; Lim JA; Kim S; Kim DY; Han SH; Jang H; Suh HI; Cho AH; Kim DW; Shin JW; Koo YS; Choi WC; Lee WW; Choi N; Kim S; Nam H; Koo DL; Kim M; Lim BC; Chae JH; Kim KJ; Jeon D; Park KI; Jung KY; Kim M; Chu K; Lee SK
J Neuroimmunol; 2016 Apr; 293():34-38. PubMed ID: 27049559
[TBL] [Abstract][Full Text] [Related]
39. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis.
Armangue T; Spatola M; Vlagea A; Mattozzi S; Cárceles-Cordon M; Martinez-Heras E; Llufriu S; Muchart J; Erro ME; Abraira L; Moris G; Monros-Giménez L; Corral-Corral Í; Montejo C; Toledo M; Bataller L; Secondi G; Ariño H; Martínez-Hernández E; Juan M; Marcos MA; Alsina L; Saiz A; Rosenfeld MR; Graus F; Dalmau J;
Lancet Neurol; 2018 Sep; 17(9):760-772. PubMed ID: 30049614
[TBL] [Abstract][Full Text] [Related]
40. Seroprevalence of N-methyl-D-aspartate glutamate receptor (NMDA-R) autoantibodies in aging subjects without neuropsychiatric disorders and in dementia patients.
Busse S; Busse M; Brix B; Probst C; Genz A; Bogerts B; Stoecker W; Steiner J
Eur Arch Psychiatry Clin Neurosci; 2014 Sep; 264(6):545-50. PubMed ID: 24604707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
